Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
94 search results for:

Bone diseases 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 19-02-2018 | Osteoporosis | Review | Article

    Marrow fat: A new target to treat bone diseases?

    Lecka-Czernik B et al. Curr Osteoporos Rep 2018; Advance online publication. doi: 10.1007/s11914-018-0426-z

  2. 08-05-2018 | Osteoarthritis | Article

    Benefits and safety of dietary protein for bone health: An expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

    This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults. Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

  3. 08-05-2018 | Osteoarthritis | Highlight | Teaser
    Journal article

    Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

    This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults [ read more ]. Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

  4. 21-06-2022 | Glucocorticoids | News | Article

    Low-dose glucocorticoids show no negative impact on BMD

    Low glucocorticoid doses are not associated with reduced bone mineral density in people with inflammatory rheumatic and musculoskeletal diseases, observational study findings indicate.

    Author:
    Laura Cowen
    Published in:
    Ann Rheum Dis 2022; doi:10.1136/annrheumdis-2022-222339
  5. 13-07-2022 | Surgery | News | Article
    guidelinesWatch

    US guidelines issued for the use of rheumatology drugs around the time of hip, knee replacement

    The American College of Rheumatology and the American Association of Hip and Knee Surgeons have issued updated recommendations to guide perioperative use of antirheumatic medications among people with rheumatic diseases undergoing total hip or knee arthroplasty.

    Author:
    Claire Barnard
    Published in:
    Arthritis Care Res 2022; doi:10.1002/acr.24893 Arthritis Rheumatol 2022; doi:10.1002/art.42140 J Arthroplasty 2022; doi:10.1016/j.arth.2022.05.043
  6. 03-06-2022 | EULAR 2022 | Conference coverage | Article

    Chronic, low-dose glucocorticoid benefits outweigh harms in senior patients with RA

    The investigators highlight that there was a “trade-off” to prednisolone’s benefit on disease activity in terms of a 24% increased risk of having at least one adverse event of special interest, including serious events, GC-specific events (such as cardiovascular events, infections, and symptomatic bone fracture), and those causing study discontinuation.

    Author:
    Lucy Piper
    Published in:
    EULAR 2022; Copenhagen, Denmark: 1–4 June Ann Rheum Dis 2022; doi:10.1136/annrheumdis-2021-221957 Ann Rheum Dis  2022; 81 : 180
  7. 16-08-2021 | Temporal cell arteritis | Teaser

    New additions to the Adis Journal Club

    A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

  8. 08-02-2022 | Temporal cell arteritis | Teaser

    Rituximab and rheumatology practice in the COVID-19 era

    How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

  9. 05-10-2021 | Rheumatoid arthritis | News | Article

    Denosumab benefits short-lived following discontinuation

    Discontinuing denosumab after 1 year of treatment quickly leads to reversal of its inhibitory effect on bone turnover markers and improvements in bone mineral density among people using glucocorticoids for rheumatoid arthritis, research shows.

    Author:
    Laura Cowen
    Published in:
    Arthritis Rheumatol 2021; doi: 10.1002/art.41981
  10. 24-05-2021 | ACR 2021 | Teaser

    ACR Convergence 2021 highlights

    3–9 November: Keep up with the latest news and interviews from the conference.

  11. 06-09-2021 | Pneumonia | Teaser

    Anifrolumab for the treatment of lupus

    Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

  12. 26-10-2020 | Vitamin D | Teaser

    Get ready for ACR Convergence 2020

    5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

  13. 10-05-2021 | Temporal cell arteritis | Teaser

    Febuxostat and cardiovascular risk in people with gout

    How will the FAST trial results impact regulatory guidance & clinical practice?

  14. 17-05-2021 | COVID-19 channel | News | Article

    NSAID use not linked to poor COVID-19 outcomes

    NSAID use is not associated with more severe disease among people admitted to hospital with COVID-19, including those with rheumatic diseases, show data from a large, prospective UK cohort study.

    Author:
    Laura Cowen
    Published in:
    Lancet Rheumatol 2021; doi:10.1016/S2665-9913(21)00104-1
  15. 18-11-2020 | Temporal cell arteritis | Teaser

    Telemedicine in rheumatology

    Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.